Sarcoma: open trials in Israel

9 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus-Pediatric Hemato-Oncology ( Site 1674), Haifa · Sheba Medical Center ( Site 1675), Ramat Gan
Registry updated 2026-10-30
NCT07261631
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Novartis Investigative Site, Haifa · Novartis Investigative Site, Tel Aviv
Registry updated 2026-10-09
NCT07602777
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Trial Treatment · Phase 1/2 · GlaxoSmithKline
GSK Investigational Site, Jerusalem · GSK Investigational Site, Tel Aviv
Registry updated 2026-10-01
NCT05697874
International Rare Brain Tumor Registry
Research · Children's National Research Institute
Rambam Health Care Campus, Haifa · Schneider Children's Medical Center- CLALIT Health Services, Petah Tikva · Dana-Dwek Children's Hospital- Tel Aviv Medical Center, Tel Aviv · The Sheba Medical Center, Tel HaShomer
Registry updated 2026-08-07
NCT04534127
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Trial Treatment · Alpha Tau Medical LTD.
Sharett institute, Hadassah Medical Center - Ein-Kerem, Jerusalem
Registry updated 2026-06-16
NCT06500715
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Trial Treatment · Shaare Zedek Medical Center
Shaare Zedek Medical Center, Jerusalem
Registry updated 2026-04-29
NCT03889899
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
Trial Treatment · Alpha Tau Medical LTD.
Rambam Health Care Campus, Haifa
Registry updated 2025-12-02
NCT05296564
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Trial Treatment · Phase 1/2 · Hadassah Medical Organization
Hadassah Medical Organization, Jerusalem
Registry updated 2025-10-02
NCT04625907
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Trial Treatment · Phase 1/2 · University of Birmingham
Rambam Health Care Campus, Haifa · Hadassah University Medical Centre, Jerusalem · Schneider Medical Centre, Petah Tikva · Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv · Chaim Sheba Medical Centre, Tel HaShomer
Registry updated 2024-05-23

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error